Overactive Bladder - Results from #1280

Current and future pharmacotherapy for treating overactive bladder June 7, 2016

Does central sensitization help explain idiopathic overactive bladder? June 7, 2016

A pilot study to measure dynamic elasticity of the bladder during urodynamics June 7, 2016

Real-life clinical practice of onabotulinum toxin A intravesical injections for overactive bladder wet: an Italian consensus statement June 1, 2016

An evaluation of the efficacy of solifenacin and darifenacin for prevention of catheter related bladder discomfort: a prospective, randomized, placebo controlled, double blind study May 23, 2016

The association of pelvic organ prolapse severity and improvement in overactive bladder symptoms after surgery for pelvic organ prolapse May 23, 2016

The bladder is not sterile: History and current discoveries on the urinary microbiome May 23, 2016

A Narrative Review of Patient-reported Outcomes in Overactive Bladder: What is the Way of the Future? May 12, 2016

Clinical characteristics, beliefs, and coping strategies among older patients with overactive bladder May 9, 2016

[Prevalence and initial management of overactive bladder in France: A cross-sectional study] May 9, 2016

Continuous positive airway pressure therapy is associated with improvement in overactive bladder symptoms in women with obstructive sleep apnea syndrome May 1, 2016

Intravesical OnabotulinumtoxinA Injection for Overactive Bladder Patients with Frailty, Medical Comorbidities or Prior Lower Urinary Tract Surgery April 26, 2016

Urothelial Dysfunction and Chronic Inflammation in Diabetic Patients with Overactive Bladder April 26, 2016

Assessing multiple dimensions of urgency sensation: The University of South Australia Urinary Sensation Assessment (USA(2) ) April 26, 2016

Biofeedback as a first-line treatment for overactive bladder syndrome refractory to standard urotherapy in children April 26, 2016

Effect of Potentially Inappropriate Use of Antimuscarinic Medications on Healthcare Use and Cost in Individuals with Overactive Bladder April 25, 2016

Intravesical OnabotulinumtoxinA Injection for Overactive Orthotopic Ileal Neobladder: Feasibility and Efficacy April 25, 2016

Assessment of Proportion of Hidden Patients Having Symptoms of Overactive Bladder and Why Has It Been Hidden in Female Outpatients Admitted to Hospital April 25, 2016

Limitations of anticholinergic cycling in patients with overactive bladder (OAB) with urinary incontinence (UI): results from the CONsequences of Treatment Refractory Overactive bLadder (CONTROL) study April 20, 2016

Health Resource Utilization and Cost for Patients with Incontinent Overactive Bladder Treated with Anticholinergics April 20, 2016

Page 65 of 122